ITP Registry and Accompanying Biospecimen Collection

Condition(s) studied

Study summary

The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.

Eligibility

Primary outcome measure(s)

• epidemiological data on ITP - Incidence — At enrollment
  Incidence: number of reported ITP, estimate incidence by zip code area
• epidemiological data on ITP - Age — At enrollment
  Age (year of birth)
• epidemiological data on ITP - Sex distribution — At enrollment
  Sex distribution: female, male
• Description of the causes of ITP — At enrollment
  causes of ITP in primary/secondary form (medical induced, autoimmune disease, Lymphoma / malignancy, infection, upon vaccination, others)
• ITP treatment type received — 5 years
  Medical therapies received
• Remission — 5 years
  Remission Status

Trial sites (64)

+ 24 more sites — see the full list on the official registry below.

More Jena University Hospital trials in Germany

Other trials for the same condition